Pulmonx up on Japan's approval of lung device
** Pulmonx Corp's shares LUNG.O rise 9.3% to $5.8
premarket
** Medical device maker says Japan has approved its
minimally invasive lung device for treating patients with lung
disease, severe emphysema urn:newsml:reuters.com:*:nBwb7b3vca
** Co plans to collaborate with Japanese government to gain
reimbursement prior to commercialization
** Up to Tuesday's close, stock was down ~83% YTD
(Reporting by Khushi Mandowara)
((Khushi.Mandowara@thomsonreuters.com;))
Recent news on Pulmonx
See all newsBrief: Pulmonx Corporation Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Pulmonx Corp reports results for the quarter ended June 30 - Earnings Summary
Pulmonx Corp Q2 revenue falls, but beats estimates
Brief: Pulmonx Q2 EPS USD -0.24
Pulmonx Corp expected to post a loss of 28 cents a share - Earnings Preview